1. |
Kaklamani V, O’Regan RM. New targeted therapies in breast cancer [J]. Semin Oncol, 2004; 31(2 Suppl 4)∶20.
|
2. |
Sanz L, Blanco B, AlvarezVallina L. Antibodies and gene therapy: teaching old ‘magic bullets’ new tricks [J]. Trends Immunol, 2004; 25(2)∶85.
|
3. |
Merdan T, Callahan J, Petersen H, et al. Pegylated polyethylenimineFab’ antibody fragment conjugates for targeted gene delivery to human ovarian carcinoma cells [J]. Bioconjug Chem, 2003; 14(5)∶989.
|
4. |
Von Rothenburg T, Schaffstein J, Ludwig J, et al. Imaging osteomyelitis with Tc99mlabeled antigranulocyte antibody Fab’ fragments [J]. Clin Nucl Med, 2003; 28(8)∶643.
|
5. |
Liu X, Zhen Y. Antitumor effects of monoclonal antibody Fab’ fragmentcontaining immunoconjugates [J]. Chin Med Sci J, 2002; 17(1)∶1.
|
6. |
Hashida S, Imagawa M, Inoue S, et al. More useful maleimide compounds for the conjugation of Fab’ to horseradish peroxidase through thiol groups in the hinge [J]. J Appl Biochem, 1984; 6(1-2)∶56.
|
7. |
Smith A, Alberto R, Blaeuenstein P, et al. Preclinical evaluation of 67Culabeled intact and fragmented anticolon carcinoma monoclonal antibody MAb35 [J]. Cancer Res, 1993; 53(23)∶5727.
|
8. |
McCall MJ, Diril H, Meares CF. Simplified method for conjugating macrocyclic bifunctional chelating agents to antibodies via 2iminothiolane [J]. Bioconjug Chem, 1990; 1(3)∶222.
|
9. |
Anderson CJ, Schwarz SW, Connett JM, et al. Preparation, biodistribution and dosimetry of copper64labeled anticolorectal carcinoma monoclonal antibody fragments 1A3F(ab’)2 [J]. J Nucl Med, 1995; 36(5)∶850.
|
10. |
Riddles PW, Blakeley RL, Zerner B. Reassessment of Ellman’s reagent [J]. Methods Enzymol, 1983; 91(1)∶49.
|
11. |
Meares CF, McCall MJ, Reardan DT, et al. Conjugation of antibodies with bifunctional chelating agents: isothiocyanate and bromoacetamide reagents, methods of analysis, and subsequent addition of metal ions [J]. Anal Biochem, 1984; 142(1)∶68.
|
12. |
SmithJones PM, Fridrich R, Kaden TA, et al. Antibody labeling with copper67 using the bifunctional macrocycle 4[(1,4,8,11tetraazacyclotetradec1yl)methyl]benzoic acid [J]. Bioconjug Chem, 1991; 2(6)∶415.
|
13. |
Parham P, Androlewicz MJ, Brodsky FM, et al. Monoclonal antibodies: purification, fragmentation and application to structural and functional studies of class I MHC antigens [J]. J Immunol Methods, 1982; 53(2)∶133.
|